UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
     
Filed by the Registrant
  þ
Filed by a Party other than the Registrant:
  o
Check the appropriate box:
      o       Preliminary Proxy Statement
      o       Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
      o       Definitive Proxy Statement
      þ       Definitive Additional Materials
      o       Soliciting Material Pursuant to ss.240.14a-12
INVENTIV HEALTH, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
             
Payment of Filing Fee (Check the appropriate box):
      þ   No fee required.
      o   Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
  (1)       Title of each class of securities to which transaction applies:
 
           
 
  (2)       Aggregate number of securities to which transaction applies:
 
           
 
  (3)       Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
           
 
  (4)       Proposed maximum aggregate value of transaction:
 
           
 
  (5)       Total fee paid:
 
           
      o   Fee paid previously with preliminary materials.
      o   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
  (1)       Amount Previously Paid:
 
           
 
  (2)       Form, Schedule or Registration Statement No.:
 
           
 
  (3)       Filing Party:
 
           
 
  (4)       Date Filed:
 
           
 
 

 

On Wednesday, May 19, 2010, inVentiv Health, Inc. issued a press release announcing an update in the start time for the Annual Meeting of Shareholders. The text of the press release is attached below.
     
(INVENTIV HEALTH LOGO)   NEWS RELEASE
FOR IMMEDIATE RELEASE
     
Investors/Corporate:
  Media:
David Bassin, CFO
  Marcia Frederick
inVentiv Health, Inc.
  inVentiv Health, Inc.
(732) 537-4804
  (614) 543-6281
investor@inventivhealth.com
  mfrederick@inventivhealth.com
inVentiv Health to Hold 2010
Shareholders Meeting on June 8 th at 1 p.m.
SOMERSET, N.J. — May 19, 2010 — inVentiv Health, Inc. (NASDAQ: VTIV) will hold its 2010 Annual Meeting of Shareholders on Tuesday, June 8 at 1 p.m. EDT. The meeting will be held at inVentiv’s midtown Manhattan office, located at 1180 Avenue of the Americas, 10 th Floor, New York, NY.
Shareholders should note that the start time for the meeting has been updated to 1 p.m. The company’s annual report and proxy statement, which were printed several weeks ago, list the meeting as starting at 9 a.m.
Shareholders also can attend the meeting via conference call. To listen, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). The conference identification number is 76749764. In addition, the meeting will be webcast live on the Internet at http://www.inVentivHealth.com/health/newsroom/webcasts.asp . To participate, please go to the site at least 15 minutes in advance of the call to register, download and install any necessary audio software.
About inVentiv Health
inVentiv Health, Inc. (NASDAQ: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health’s client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com .
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
# # #
         
 
       
inVentiv Health
  www.inventivhealth.com    
 
  500 Atrium Drive • Somerset, New Jersey • 08873 • p.800.416.0555    

Ventiv Health (NASDAQ:VTIV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Ventiv Health Charts.
Ventiv Health (NASDAQ:VTIV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Ventiv Health Charts.